chrisvoncsefalvay/vaers-outcomes huggingface dataset:
psoriasis flared up/psoriasis flared up even more; itching and having all the stuff; I've never had so many plaques before; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (psoriasis flared up/psoriasis flared up even more), PRURITUS (itching and having all the stuff) and PSORIASIS (I've never had so many plaques before) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Psoriasis. Concurrent medical conditions included Blood pressure high. Concomitant products included LISINOPRIL for Blood pressure high.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PSORIASIS (psoriasis flared up/psoriasis flared up even more), PRURITUS (itching and having all the stuff) and PSORIASIS (I've never had so many plaques before). At the time of the report, PSORIASIS (psoriasis flared up/psoriasis flared up even more), PRURITUS (itching and having all the stuff) and PSORIASIS (I've never had so many plaques before) outcome was unknown.
contracted polymyalgia rheumatica-dx 6wk p/vax;7-10 days p/vax woke up w/stiff, sore lower back;stiff achy back became stiffer & more sore as time passed;pain in upper rt arm/shoulder followed by pain in lt arm & shoulder;
Within 5 minutes or so after receiving vaccination I had sudden & unexplainable excessive coughing, feeling like my throat was restricted & issues catching my breath for probably 5 minutes.  At the time I didn?t realize this could very well be an immediate allergic reaction so I didn?t report it to the medical staff at the vaccine location.  There was no other symptoms & it resolved & I was back to normal after approximately 5 minutes of struggling with this,
Patient complained of dizziness, nausea, headaches (similar to the 1st dose) starting this morning (around 24 hours after receiving the shot). However, there's chest pain & shortness of breath this time.  Pt said she could not breath without opening her mouth. She tried Tylenol 500mg & Ibuprofen 800mg today, but the symptoms could not resolved or better. I told patient to see urgent care tonight and let us know later.
rash, shortness of breathe, sever trouble breathing, high fever, vomiting, Diarrhea, body chills , headache, numbness in hands and feet. went to e.r. was treated for allergic reaction and pain. discharged with fever and continued vomiting for next 12 hours. rash continued for 5 days. when rash went away pain in the arm causing loss of use and unable to work still current as of day 9 after vaccine.
Evening of 10-16-07 noticed blotchy, fine red rash on legs. Eventually spread to torso and arms. Took Benadryl. This morning rash still present, mild itchiness, did not take anymore Benadryl. No SOB, chest pains or other systemic sx. Referred to PMD for evaluation ~ has appointment this afternoon.
pneumonia; Initial information received on 07-Dec-2020 regarding an unsolicited valid serious social media case received from a consumer (patient).  This case involves a patient of unknown demographic who experienced pneumonia, after the patient received INFLUENZA VACCINE.  Medical history, concomitant medications, past medical treatment, vaccination and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, expiration date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious pneumonia (Unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  It was stated that the patient never took another shot.   Relevant laboratory data was not reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the patient outcome was Unknown for pneumonia.  There will be no information available on the batch number for this case.; Sender's Comments: This case involves a patient who experienced pneumonia, while he/she received vaccine INFLUENZA VACCINE. Time to onset is unknown. However, additional information on patients medical condition at the time of vaccination, concomitant medication and investigations ruling out other etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
Headache & HYPERtension Narrative: Stayed 30 minutes. headache resolved. Reports could be related to new med Pregabalin
Vaccinated months ago and now they have diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Vaccinated months ago and now they have diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 013M20A) for COVID-19 vaccination.     No relevant medical history reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Vaccinated months ago and now they have diarrhea). At the time of the report, DIARRHOEA (Vaccinated months ago and now they have diarrhea) outcome was unknown. No treatment information was provided. The patient enquired about the booster dose. Limited information regarding the event has been provided at this time and a causal relationship cannot be excluded.  It is unclear how long after previous administration of the vaccine the diarrhea occurred and whether it is associated with the vaccine.; Sender's Comments: Limited information regarding the event has been provided at this time and a causal relationship cannot be excluded.  It is unclear how long after previous administration of the vaccine the diarrhea occurred and whether it is associated with the vaccine.
Pityriasis Rosea, which began several days to weeks after the vaccine with one spot on the right leg/ankle. Weeks later it developed and spread across body from top of neck to groin area with some lighter occurrences of plaques on arms and legs. Patient's sister developed the same reaction of pityriasis rosea on about the same timeline after her covid vaccinations.
I received a Moderna booster vaccine dose on 11/05/2021 and was hospitalized shortly after with a CVA/stroke which I received physical deficit and am still recovering.
pt developed reddened area on anterior & inside of rt thigh; with dark purple area the size of nickel inside reddened area;
she is now experiencing light headedness; This is a spontaneous report received from a contactable reporter (Consumer) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as DOSE 1, SINGLE for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "she is now experiencing light headedness".  No follow-up attempts are possible. No further information is expected.
This case was medically confirmed in the follow-up, previously it was from Non healthcare professional. The case was linked with the case number 2014SA011902. Initial case was received from a other non healthcare professional on 26 January 2014. A 29 year old male patient whose medical history and concomitant medication was not reported had received an intradermal FLUZONE ID (batch number: UT4728BA, dose not reported) on the left forearm on 24 January 2014. The patient did not have illness at the time of vaccination and pre-existing physician diagnosed allergies, birth defects or medical conditions were none. On 24 January 2014, the patient developed a large area of redness and swelling with raised red bumps at the injection site on the left forearm where the vaccine was administered by the pharmacist. Corrective treatment or laboratory investigations were not reported. The outcome of the event was unknown. The list of documents held by sender: none. Follow up information was received from consumer on 27 January 2014. The cases were received on 21 March 2014. It was confirmed that after hrs. 01.26.14 8:10 pm. called regarding site reactions, the dose of vaccine was administered by pharmacist in the left forearm and not in to the deltoid stated in the PI. Follow up information received from a health care professional on 05-May-2014: It was reported that the patient reviewed flair cleared up on it own after 5 days. The patient was recovered from adverse event on an unspecified date.
At approx 3-4min after injection pt appeared lethargic and bobbing head.  Administering technician went to her and asked if ok, she leaned against technician and closed eyes.  Pt was not verbal, but continued to open eyes and blink very slowly.  We contacted 911 - pt continued to be non verbal for about 5 more minutes.  911 advised nothing by mouth and to move to lying position if pt became unconscious (which she did NOT).  Paramedics arrived and pt was able to speak with them and complete a report.  Pt left walking out with paramedics.
Shaky; Nauseous; Shortness of breath after going up staircase; Felt weak; Cancer drug causes loss of balance; The patient was ready to die, the pain was incredible; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (Cancer drug causes loss of balance), PAIN (The patient was ready to die, the pain was incredible), DYSPNOEA EXERTIONAL (Shortness of breath after going up staircase), ASTHENIA (Felt weak) and NERVOUSNESS (Shaky) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058Z21A, 013A21A and 012M2BA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Breast cancer and Migraine. Concomitant products included AMITRIPTYLINE, DIAZEPAM, FLURAZEPAM and PERPHENAZINE for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Aug-2021, the patient experienced BALANCE DISORDER (Cancer drug causes loss of balance) and PAIN (The patient was ready to die, the pain was incredible). On 28-Aug-2021, the patient experienced ASTHENIA (Felt weak). On 29-Aug-2021, the patient experienced DYSPNOEA EXERTIONAL (Shortness of breath after going up staircase). On an unknown date, the patient experienced NERVOUSNESS (Shaky) and NAUSEA (Nauseous). The patient was treated with IBUPROFEN for Pain, at a dose of 400 mg every six hours. At the time of the report, BALANCE DISORDER (Cancer drug causes loss of balance), PAIN (The patient was ready to die, the pain was incredible), DYSPNOEA EXERTIONAL (Shortness of breath after going up staircase), ASTHENIA (Felt weak), NERVOUSNESS (Shaky) and NAUSEA (Nauseous) outcome was unknown.            Concomitant product included breast cancer pill. Patient planned to see cardiologist for echocardiogram and blood test.  The patient has been tapering the doses of breast cancer pill and reported that 2 days ago, the patient tapered one of them and asked whether this was the cause of symptoms. The patient did not have a history of myocarditis/pericarditis and COVID-19 infection.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset of the events, a causal relationship cannot be excluded. Causality is confounded by the patient's history of breast cancer.
MMR vaccine administered on 10/13/08.  Fever 101.7 beginning 10/19/08. Runny nose 10/22/08-present.  Rash on trunk, face, back and arms beginning 10/23/08. Decreased apppetite and increased fussiness 10/23/08.
Patient had 20cm x 6cm erythematous rash with itchiness 5 days after tdap injection. It's on Right upper arm.
Thursday, February 25, 2020 woke up with having numbness, no dexterity in fingers/ right hand.
Pt reported a very sore arm after the immunization. Difficult to move. She said it has improved but is still sore 9 days later.
2 days after flu shot, woke up with muscle pain and stiffness in left arm and should (site of shot).  Nightly for about 1 week after first episode,continued to be awakened by muscle pain expanding to right arm, shoulder, then in buttocks and down back of both legs.  Took 200 mg Ibuprofin each night with some relief.  Seemed to "loosen up during the daytime and worsen at night.  Approximately, lweek after symptoms started saw new MD who did an exam, drew blood and checked prostate.  At a 2nd MD visit to obtain lab results, all labs were WNL.  Client started taking "Miricle Mix", something he found on the internet, which seems to be helping "a little".  3rd MD visit planned after Thanksgiving.
after getting the covid booster shot (4 days after getting the flu shot) I broke out in a red rash all over my body.; I have psoriasis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), as dose number unkown, single (Batch/Lot number: unknown) for immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series , Manufacture unknown), for COVID-19 Immunization. The following information was reported: RASH ERYTHEMATOUS (non-serious), outcome "unknown", described as "after getting the covid booster shot (4 days after getting the flu shot) I broke out in a red rash all over my body."; PSORIASIS (non-serious), outcome "unknown", described as "I have psoriasis". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient reported that immediately after getting the covid booster shot (4 days after getting the flu shot) patient broke out in a red rash all over patient body. The treatment the doctor was prescribing was very expensive. was there any financial help available to cover this. The doctor did a biopsy and determined patient had psoriasis. There was no history of this in patient family and had no health issues until patient got the booster shot.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report as received from a nurse, refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug allergies/reactions and concomitant medications, if any, were not reported. On an unknown date, the patient was vaccinated with improperly stored VARIVAX subcutaneously (which had a lot # of N027628 and an expiration date on 04-OCT-2019; however, dosage number and anatomical site of administration were not provided), for prophylaxis. Nonetheless, no adverse effects were reported. The vaccine experienced the following temperature excursion: 15 degrees Fahrenheit to 46 degrees Fahrenheit (-9 degrees Celsius to 8 degrees Celsius) (-7.8 degrees Celsius)) for 10 minutes on unspecified date. Reportedly, there had been no previous temperature excursions and the aforementioned temperatures were identified due to a data logger.
5 minutes after patient received the vaccine he became pale. Then 2 minutes later he passed out and began to shake. Emergency care staff on scene after 30 sec of reaction.
The pt experienced arthralgia to the elbows, hands and knees occurring 4 days post vax. Pain and stiffness was worse when placing pressure on joints. Itching of hands and feet. No fever or other symptoms.
patient was only given the DtaP/ IPV, however she did not receive the ActHIB powder portion of the Pentacel vaccine, no adverse event; Initial information received on 19-Nov-2019 regarding an unsolicited valid non-serious case from an other health care professional.  This case involves a two months old female patient who was vaccinated with a 0.5 ml first dose of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (lot UJ134AA and expiration date 11-Oct-2020) via an intramuscular route in the left thigh on 07-Nov-2019. However she was only given the Dtap/ Ipv portion and did not receive the Act-Hib powder portion of the pentacel vaccine.  Medical history not reported and concomitant medications included HEPATITIS B VACCINE (HEPATITIS B VACCINE), ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) and PNEUMOCOCCAL VACCINE POLYSACCH 23V (PNEUMOVAX 23) for Immunisation received on 07-Nov-2019.  It was an actual medication error case due to inappropriate reconstitution technique.  No adverse event reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Infant went to sleep immediately after injections. Mother awakened her at 7 pm, with temp 101 gave motrin.  Took a little formula and went back to sleep.  Awakened at 9 pm temp 101. Very lethargic et choked et spit up when fed. Lethargy lasted 20-30 min called nurse who came et stimulated infant. temp continued 1 1/2 day at 101 with motrin given every 6 hours 1 dose had been given prior to injections.
Confusion 6 days after shot. Within a week lost ability to walk, became urinary incontinent. Major chest congestion, slept all the time. Rushed by ambulance at day 12.. Diagnosed with pneumonia amd uti. Cardiac arrest at day 14, never woke up. Taken off life support 3/20/21.
No additional AEs were reported; patient received improperly stored vaccine; This spontaneous report was received from a medical assistant referring to an unknown age and gender patient. The patient's concurrent condition, medical history, and concomitant medications were not reported.   Varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot# W032370 [reported as w032370], expiry date was reported as 19-APR-2025, but upon internal validation established as 10-OCT-2024) was stored at temperature of 37.2 degree Fahrenheit (F) for 18 hours. There was no previous temperature excursion. On 06-SEP-2023, after temperature excursion, the patient was vaccinated with 1 dose of the improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) injection (exact dose, route of administration, and anatomical location not provided) as prophylaxis (product storage error). No additional adverse events (AEs) were reported (no adverse event). No further information was provided.  This is one of 4 reports received from the same reporter.
This spontaneous report as received from a pharmacist via company representative refers to a 77 year old male patient. Patient historical drugs included unspecified flu vaccine administered in October 2014. On 17-DEC-2014, the patient was vaccinated with ZOSTAVAX (lot number Expiry date, dose, route were not reported), Concomitant therapies included TD administered in November 2014. The pharmacist stated that the patient's wife informed him 02-24-2014 that the patient developed "something similar to shingles" on an unspecified date in December 2014. The patient went to unspecified emergency room and was diagnosed with shingles. It was unsure if the patient was hospitalized. On 08-JAN-2015 the pharmacist confirmed the patient's diagnosis of shingles. The outcome of the event was not reported. The relatedness between the event and ZOSTAVAX was not reported. Additional information has been requested.
5/8 12y.o. female with PMH of irregular menstruations who presented on 5/8/2022 for acute abdominal pain. Pediatric radiology reviewed available imaging and felt that the CT was not indicative of appendicitis. She was determined to be ready for discharge to home in the afternoon on 5/9.
gave me bad headache; This case was reported by a consumer via  interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included rash (had rash in eye) and headache (had absolutely horrid nonstop headaches). Previously administered products included Shingles vaccine with an associated reaction of illness (received 1st dose on an unknown date and experienced sickness for tolerance refer case US2021AMR183327). Concurrent medical conditions included scar.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced headache. On an unknown date, the outcome of the headache was unknown.   It was unknown if the reporter considered the headache to be related to Shingles vaccine.  Additional details were reported as follows: The patient self-reported this case. The patient was 49 years old and had asked for vaccine before and was told not old enough.  The patient went to emergency room with rash in eye and absolutely horrid nonstop headaches.  The patient had scars on his/her face. The patient got second dose of Shingles vaccine and experienced bad headache. The patient went to emergency room.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR183327:Same reporter
Swollen eye area around filler; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 16:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 15:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 23:00, the patient experienced swollen eye area around filler. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of reported event which included treatment with diphenhydramine hydrochloride (BENADRYL). The clinical outcome of the event swollen eye area around filler was recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Severe Shoulder pain at the time of injection.  Pain improved but recently worsening.  Sometimes radiating to elbow and shooting pain center of shoulder when lifting arms over head to remove clothing. Also a general all over muscle pain that comes and goes started over past few days.